Document is current
Any future updates will be listed below
-
Authors
Nordkild, Sophie Bull
Klubien, Jeanett
Akdag, Delal
O’Rourke, Colm
Georgsen, Jeanette Baehr
Nielsen, Patricia Switten
Steiniche, Torben
Villadsen, Gerda Elisabeth
Knudsen, Anders Riegels
Willemoe, Gro Linno
Andersen, Jesper Bøje
Nielsen, Susanne Dam
Pommergaard, Hans-Christian Lykkegaard
-
Funding
Funding for this research was provided by:
National Hospital
- License Information
-
More Information
Article History
Received: 10 December 2025
Accepted: 5 April 2026
First Online: 15 April 2026
Declarations
:
: The study was approved by the Central Denmark Region Committees on Health Research Ethics (journal-nr.: 1-10-72-104-17).
: During the preparation of this work, the authors used ChatGPT from OpenAI to improve clarity, grammar and readability of the manuscript. After using this tool/service, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.
: Informed consent has been obtained by all participants.
: HC Pommergaard: Research grants from Danish Cancer Society, Svend Andersen Fund, Harboe Fund, Dagmar Marshalls Fund, and The Danish National Center for Circulating Tumor DNA Guided Cancer Treatment.SD Nielsen: Research grant from Novo Nordic Foundation and participation in advisory board for Gilead, Merck, and GSK.GE Villadsen: Vingmed A/S, Sirtex EU, Astra-Zeneca DenmarkSB Nordkild, J Klubien, D Akdag, CJ O’Rourke, JB Georgsen, PS Nielsen, T Steiniche, GE Villadsen, AR Knudsen, GL Willemoe, JB Andersen: Declarations of interest: none.
